Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES). [PDF]
Osteoporos IntJain RK.
europepmc +1 more source
Effect of zoledronate on avascular necrosis of the femoral head according to disease stage and bone resorption activity. [PDF]
J Orthop Surg ResMoksi L +4 more
europepmc +1 more source
Related searches:
[New bone density conservation agents for osteoporosis under research and development: Ibandronate].
Nihon rinsho. Japanese journal of clinical medicine, 2008Ikuko, Tanaka +2 more
openaire +1 more source
[New bone density conservation agents for osteoporosis under research and development: Zoledronate].
Nihon rinsho. Japanese journal of clinical medicine, 2008Seiki, Wada +2 more
openaire +1 more source
Aging and osteoporosis in breast and prostate cancer
Ca-A Cancer Journal for Clinicians, 2011Ari VanderWalde, Arti Hurria
exaly
[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Nihon rinsho. Japanese journal of clinical medicine, 2008Itsuro, Endo, Toshio, Matsumoto
openaire +1 more source
Seiki, Wada +2 more
openaire +1 more source
Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back
Ca-A Cancer Journal for Clinicians, 2014Giada Bianchi, Kenneth C Anderson
exaly
The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer
Ca-A Cancer Journal for Clinicians, 1996Frederick R Appelbaum
exaly